Trials / Completed
CompletedNCT02998151
Neurophysiological and Acute Pharmacological Studies in FXS Patients
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- Children's Hospital Medical Center, Cincinnati · Academic / Other
- Sex
- All
- Age
- 15 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to utilize neurophysiologic assessments, behavioral measures and clinical measures to assess how much deficits associated with Fragile X Syndrome from pre-dose to post-dose using pharmacology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Acamprosate | two 666mg pills |
| DRUG | Lovastatin | two 20mg pills |
| DRUG | Minocycline | two 135mg pills |
| DRUG | Placebo | placebo pill |
| DRUG | Baclofen | one 30mg pill |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2020-11-01
- Completion
- 2020-11-01
- First posted
- 2016-12-20
- Last updated
- 2021-11-26
- Results posted
- 2021-11-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02998151. Inclusion in this directory is not an endorsement.